Projects funded by the NCN
Bionanoparticles with a molecular targeting device as a weapon for breast cancer
2022/45/B/NZ7/03889
Keywords:
breast cancer nanoparticles peptides fibril self-assembling drug carrier HER2 antibody affibody doxorubicin nanodrugs
Descriptors:
- NZ5_7: Human disease treatment
- ST4_9: Biological chemistry
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Gdański, Wydział Chemii
woj. pomorskie
Principal investigator (from the host institution):
prof. Sylwia Rodziewicz-Motowidło
Number of co-investigators in the project: 8
Call: OPUS 23 - announced on 2022-03-28
Amount awarded: 2 396 080 PLN
Project start date (Y-m-d): 2023-09-28
Project end date (Y-m-d): 2027-09-27
Project duration:: 48 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.